3-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid → HCID 117727813, 화합물
반응식
[NH2:1][CH2:2][C@@H:3]1[C@H:8]([CH3:9])[CH2:7][CH2:6][CH2:5][N:4]1[C:10]([C:12]1[CH:17]=[C:16]([CH3:18])[CH:15]=[CH:14][C:13]=1C1C=NN(C)C=1)=[O:11].CC1C([N:35]2[N:39]=[CH:38][CH:37]=[N:36]2)=C(C=CC=1)C(O)=O>>[NH2:1][CH2:2][C@@H:3]1[C@H:8]([CH3:9])[CH2:7][CH2:6][CH2:5][N:4]1[C:10]([C:12]1[CH:13]=[CH:14][CH:15]=[C:16]([CH3:18])[C:17]=1[N:35]1[N:39]=[CH:38][CH:37]=[N:36]1)=[O:11]참가 물질
3
실험 절차
The title compound was prepared following the same general protocol as described for ((2S,3R)-2-(aminomethyl)-3-methylpiperidin-1-yl)(5-methyl-2-(1-methyl-1H-pyrazol-4-yl)phenyl)methanone in Example A1 using 3-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid. MS (ESI) 314(M+H).
출처 및 근거
- ORD 기록
- ord-02b7f05cd5914b4088b04c517527c0e2
- 출처 데이터셋
- uspto-grants-2016_09